Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 38 (1-2), 27-31
- https://doi.org/10.1016/0021-9150(81)90100-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthomaAtherosclerosis, 1980
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseLipids, 1979
- Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductaseAtherosclerosis, 1979
- Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Breeding of a Rabbit Strain of Hyperlipidemia and Characteristic of These StrainExperimental Animals, 1977
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976
- Dietary and Drug Treatment of Primary HyperlipoproteinemiaAnnals of Internal Medicine, 1972